These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 31153970)

  • 1. Oxidative stress and Parkinson's disease: conflict of oxidant-antioxidant systems.
    Hemmati-Dinarvand M; Saedi S; Valilo M; Kalantary-Charvadeh A; Alizadeh Sani M; Kargar R; Safari H; Samadi N
    Neurosci Lett; 2019 Sep; 709():134296. PubMed ID: 31153970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Nrf2 signaling pathway and oxidative stress by resveratrol for Parkinson's disease: an overview and update on new developments.
    Zamanian MY; Parra RMR; Soltani A; Kujawska M; Mustafa YF; Raheem G; Al-Awsi L; Lafta HA; Taheri N; Heidari M; Golmohammadi M; Bazmandegan G
    Mol Biol Rep; 2023 Jun; 50(6):5455-5464. PubMed ID: 37155008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abrogating Oxidative Stress as a Therapeutic Strategy Against Parkinson's Disease: A Mini Review of the Recent Advances on Natural Therapeutic Antioxidant and Neuroprotective Agents.
    Theofanous T; Kourti M
    Med Chem; 2022; 18(7):772-783. PubMed ID: 35249501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative Stress: A Key Modulator in Neurodegenerative Diseases.
    Singh A; Kukreti R; Saso L; Kukreti S
    Molecules; 2019 Apr; 24(8):. PubMed ID: 31013638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individual susceptibility has a major impact on strong association between oxidative stress, defence systems and Parkinson's disease.
    Karahalil B; Miser Salihoğlu E; Elkama A; Orhan G; Saygın E; Yardim Akaydin S
    Basic Clin Pharmacol Toxicol; 2022 Jan; 130(1):158-170. PubMed ID: 34582115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease?
    de Vries HE; Witte M; Hondius D; Rozemuller AJ; Drukarch B; Hoozemans J; van Horssen J
    Free Radic Biol Med; 2008 Nov; 45(10):1375-83. PubMed ID: 18824091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological strategies to lower crosstalk between nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and mitochondria.
    Koju N; Taleb A; Zhou J; Lv G; Yang J; Cao X; Lei H; Ding Q
    Biomed Pharmacother; 2019 Mar; 111():1478-1498. PubMed ID: 30841463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Danshensu protects against 6-hydroxydopamine-induced damage of PC12 cells in vitro and dopaminergic neurons in zebrafish.
    Chong CM; Zhou ZY; Razmovski-Naumovski V; Cui GZ; Zhang LQ; Sa F; Hoi PM; Chan K; Lee SM
    Neurosci Lett; 2013 May; 543():121-5. PubMed ID: 23562886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apocyanin, a Microglial NADPH Oxidase Inhibitor Prevents Dopaminergic Neuronal Degeneration in Lipopolysaccharide-Induced Parkinson's Disease Model.
    Sharma N; Nehru B
    Mol Neurobiol; 2016 Jul; 53(5):3326-3337. PubMed ID: 26081143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safranal prevents rotenone-induced oxidative stress and apoptosis in an in vitro model of Parkinson's disease through regulating Keap1/Nrf2 signaling pathway.
    Pan PK; Qiao LY; Wen XN
    Cell Mol Biol (Noisy-le-grand); 2016 Dec; 62(14):11-17. PubMed ID: 28145852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of NADPH oxidase by apocynin prevents learning and memory deficits in a mouse Parkinson's disease model.
    Hou L; Sun F; Huang R; Sun W; Zhang D; Wang Q
    Redox Biol; 2019 Apr; 22():101134. PubMed ID: 30798073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Selenium compounds in redox regulation of inflammation and apoptosis].
    Rusetskaya NY; Fedotov IV; Koftina VA; Borodulin VB
    Biomed Khim; 2019 Apr; 65(3):165-179. PubMed ID: 31258141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sanguisorbae radix protects against 6-hydroxydopamine-induced neurotoxicity by regulating NADPH oxidase and NF-E2-related factor-2/heme oxygenase-1 expressions.
    Oh H; Hur J; Park G; Kim HG; Kim YO; Oh MS
    Phytother Res; 2013 Jul; 27(7):1012-7. PubMed ID: 22933385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NOX4 as a critical effector mediating neuroinflammatory cytokines, myeloperoxidase and osteopontin, specifically in astrocytes in the hippocampus in Parkinson's disease.
    Boonpraman N; Yoon S; Kim CY; Moon JS; Yi SS
    Redox Biol; 2023 Jun; 62():102698. PubMed ID: 37058998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo ROS production and use of oxidative stress-derived biomarkers to detect the onset of diseases such as Alzheimer's disease, Parkinson's disease, and diabetes.
    Umeno A; Biju V; Yoshida Y
    Free Radic Res; 2017 Apr; 51(4):413-427. PubMed ID: 28372523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidant Mechanisms in Renal Injury and Disease.
    Ratliff BB; Abdulmahdi W; Pawar R; Wolin MS
    Antioxid Redox Signal; 2016 Jul; 25(3):119-46. PubMed ID: 26906267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From Physiological Redox Signalling to Oxidant Stress.
    Ward JPT
    Adv Exp Med Biol; 2017; 967():335-342. PubMed ID: 29047097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging.
    Jomova K; Raptova R; Alomar SY; Alwasel SH; Nepovimova E; Kuca K; Valko M
    Arch Toxicol; 2023 Oct; 97(10):2499-2574. PubMed ID: 37597078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear factor erythroid 2-related factor 2 signaling in Parkinson disease: a promising multi therapeutic target against oxidative stress, neuroinflammation and cell death.
    Kumar H; Koppula S; Kim IS; More SV; Kim BW; Choi DK
    CNS Neurol Disord Drug Targets; 2012 Dec; 11(8):1015-29. PubMed ID: 23244425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.